June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Effect of hyaluronic acid on tear film thickness as assessed with ultra-high resolution optical coherence tomography
Author Affiliations & Notes
  • Semira Kaya
    Department of Ophthalmology /Optometrics, Paracelsus Medical University, Salzburg, Austria, Salzburg, Austria
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
  • Doreen Schmidl
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Leopold Schmetterer
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Gerhard Garhofer
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
  • Rene Werkmeister
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Footnotes
    Commercial Relationships Semira Kaya, None; Doreen Schmidl, None; Leopold Schmetterer, None; Gerhard Garhofer, None; Rene Werkmeister, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4482. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Semira Kaya, Doreen Schmidl, Leopold Schmetterer, Gerhard Garhofer, Rene Werkmeister; Effect of hyaluronic acid on tear film thickness as assessed with ultra-high resolution optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4482.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The aim of the present study was to assess the effect of a single drop of hyaluronic acid on tear film thickness (TFT) in healthy subjects.

Methods: 16 healthy subjects (8 male/ 8 female) aged between 20 and 36 years were included in this randomized, double-masked, placebo-controlled study. One eye received a single dose of hyaluronic acid eye drops (Olixia pure®, Croma Pharma, Korneuburg, Austria), the fellow eye received physiologic saline solution as placebo control. The study eye was chosen randomly. TFT as measured with a custom built Fourier-domain optical coherence tomography (FD-OCT) system was the main outcome variable and measured before and every 10 minutes until 1 hour after topical administration.

Results: Baseline TFT was 4.8 ± 0.5 µm in the study eye and 5.0 ± 0.4 µm in the control eyes. Hyaluronic acid significantly increased TFT (p = 0.008 versus placebo) with a maximum effect 10 minutes after instillation (13.9 ± 11.9%). Post-hoc analysis revealed that an increase in TFT was seen until 30 minutes after administration compared to placebo. Data in the placebo group show high reproducibility with an intraclass correlation coefficient of 0.93 and a coefficient of variation of 5.4 ± 3.3%.

Conclusions: The data of the present study indicate that hyaluronic acid increases TFT for as long as 30 minutes in healthy subjects. In addition, our data provide evidence that our custom-built OCT system is capable of measuring residence time of lubricants on the ocular surface.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×